Home  /  Capabilities  /  Clinical Trials Intelligence
Capability 02 · Clinical Trials Intelligence Platform

From Fragmented Trial Data to Live Decisions

One view of every study, site, subject, investigator, kit and dirham, built from the CTMS, EDC, eTMF and finance data already inside your walls. Not an IT tool: a sponsor-acquisition and regulatory-positioning asset.

In partnership withBaltcore
The Problem

What Fragmented Trial Data Costs

Most research organisations still manage trials through monthly reports stitched together from separate systems. By the time a problem is visible, it is already expensive.

80%

Miss enrolment timelines

Shortfalls surface in monthly reports, not in real time.

~25%

Of trials discontinue

Recruitment and retention failures show in the data first.

LOCK

Database lock at risk

Slow query resolution erodes timelines and sponsor trust.

GCP

Weak audit readiness

No single exportable trail for regulator inspection.

Problem statistics: industry benchmarks.

Why Now

The UAE Is Scaling Clinical Research

A national regulator

Federal Decree-Law 38/2024 (in force January 2025) brings trial approvals and site licensing under the Emirates Drug Establishment, with DoH and DHA adding emirate-level standards.

Volume and speed

About 400 clinical research trials are under way in Abu Dhabi alone, and electronic submissions bring full approvals down to roughly 2–3 months.

Advanced therapies are arriving

First-in-UAE gene-therapy, gene-editing and stem-cell trials, plus hospital-led CAR-T programmes with local manufacturing.

Incentives to win sponsors

A federal R&D tax credit (from January 2026) covers trial-participant payments, and the national Clinical Research Forum calls for a coordinated ecosystem.

Sources: Federal Decree-Law 38/2024; DoH Abu Dhabi via Clinical Trials Arena (2025); Abu Dhabi Media Office (2025–26); Cabinet Decision 215/2025; WAM (Dec 2025).

Clinician reviewing MRI scans on a tablet beside a laptop
The Platform

Eight Linked Dashboards, One Source of Truth

A live Power BI environment covering portfolio health, enrolment and sites, patients, timelines, quality and compliance, investigational product, financials and sponsor-level study detail.

Portfolio overview dashboard
Portfolio OverviewAlert board across enrolment, quality, IP and finance
Enrolment and sites dashboard
Enrolment & SitesFunnel, site league table, start-up days
Quality, safety and compliance dashboard
Quality, Safety & ComplianceQuery aging, deviations, SAE timeliness
Financials and budget dashboard
Financials & BudgetBurn vs plan, variance, what-if reallocation

Screens show synthetic demonstration data for a fictional research network. Platform developed in partnership with Baltcore.

Our Technology Partner

Built in Partnership With Baltcore

The platform is developed and supported jointly by Navi Lifesciences and Baltcore, an Abu Dhabi data and AI firm that designs decision dashboards, builds the governed data foundations beneath them and deploys AI agents that act on the results.

Clients get one accountable team. Clinical-research expertise and data engineering work side by side, from KPI design through to live dashboards and ongoing support.

Visit baltcore.com →

Navi Lifesciences brings
  • Clinical-research and sponsor domain expertise
  • KPI framework and role-based view design
  • Stakeholder alignment with PIs, research offices and sponsors
  • Regulatory and sponsor-acquisition positioning
Baltcore brings
  • Power BI dashboard design and build
  • Governed data foundations across CTMS, EDC, eTMF and finance
  • Integration, validation and managed support
  • AI agents that act on the insights
KPI Framework

Seven KPI Categories, Each Tied to a Decision

CategoryWhat we measureDecision it drives
EnrolmentEnrolment vs target, screen-fail rate, days to 80%Flags lagging sites and triggers strategy shifts
RetentionDropout by site, visit-schedule completionSurfaces tolerability and consent issues early
Site ActivationStart-up days (IRB to FPI), deviations, visit adherenceIdentifies sites for reallocation
TimelinesIRB approval, FPI, LPO, database lockExposes bottlenecks that extend cost
Data QualityQuery volume and aging, entry lag, % SDV completeProtects integrity ahead of lock
Safety & ComplianceSAE/AE timeliness, deviations, monitoring visitsKeeps the site inspection-ready
FinancialsBudget burn vs plan, cost per patient, milestonesProtects contract profitability
Who Sees What

Role-Based Views for Every Decision-Maker

CXO & Research Leadership

Portfolio enrolment, trials by phase and therapy area, budget health, sponsor mix and regulatory positioning.

Principal Investigators & CRCs

Enrolment funnel, query aging, visit adherence and SAE timeliness.

CRAs & Monitors

Deviation heat maps, monitoring-visit status and ISF readiness.

BD & Feasibility

Performance benchmarks, feasibility metrics and therapy-area capacity to win new studies.

Sponsors & CROs

A read-only KPI summary, compliance indicators and milestone tracking.

Engagement Plan

Five Phases, Live in 16–20 Weeks

3–4 wk

Discovery & Data Mapping

Audit CTMS, EDC and eTMF; interview PIs and the research office; define the KPI taxonomy.

3 wk

Design & Architecture

Role-based views, the Power BI layer and governance rules.

6–8 wk

Build & Integration

Connect source systems, automate data pipelines and build the dashboards.

2–3 wk

Validation & UAT

GCP-compliant validation and user acceptance testing with clinical operations and PIs.

2 wk

Rollout & Training

Role-based training, a governance SOP, update cadence and audit trail.

See Your Trial Portfolio in One View

For hospital networks, research institutes, sponsors and CROs. Request a walkthrough of the live demo.

Request a Demo